Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically starting at 2.5 mg for 4 weeks, then increasing by 2.5 mg every 4 weeks as tolerated (through intermediate steps of 5 mg, 7.5 mg, 10 mg, 12.5 mg) to a maintenance dose of 5 mg, 10 mg, or 15 mg based on individual response and tolerability
This should include: Regular weight and BMI measurements Blood tests to monitor metabolic parameters, kidney function, and nutritional status Assessment of side effects and tolerability Evaluation of weight loss progress against established targets Review of overall health and wellbeing Finally, discuss realistic expectations and long-term sustainability
If you are evaluating Empower, weigh the reviews against your own risk tolerance
Peptides are investigational and not FDA-approved, but early animal studies show promise
GLP-1 medications are available by prescription only, so you will need to have a consultation with a provider before switching to a new medication
Release and Function of GLP-1 GLP-1 is a hormone, or chemical messenger, that gets released during digestion